New genetic discovery could lead to treatment for PSP
In The Conversation, Dr. Joe Abisambra details the first evidence linking key proteins in the development of progressive supranuclear palsy.
In The Conversation, Dr. Joe Abisambra details the first evidence linking key proteins in the development of progressive supranuclear palsy.
An MBI research team has discovered a molecular mechanism driving a toxic buildup of the protein tau in PSP.
MBI researchers demonstrate a next-generation method to peer into tiny molecules in the brain made by metabolism, the chemical processes that break down food, drugs or chemicals.
Drs. Jose Abisambra and Ramon Sun join the MBI leadership team to build community and expand access to technology.
Dr. Joe Abisambra co-chairing Alzheimer’s Association International Conference Neuroscience Next